Tarceva - Small Molecule EGFR-Tyrosine Kinase Inhibitor for Cancer

Print-Icon
Print

Tarceva works by inhibiting receptor tyrosine kinase activity, the protein product of the EGFR gene. (Source: ABPI)
 
«Back | Next»

  • Tarceva cancer drug
  • Solid tumours
  • Inhibiting receptor tyrosine kinase activity
  • Roche R&D Centre


| 1 | 2 | 3 | 4 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development